EP3612537
Pýrrólóbensódíasepín samtengingar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.4.2018EP published:
13.7.2022EP application number:
18718452.8
EP translation filed:
22.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
17.4.2038Expiry date:
17.4.2026Next due date:
30.4.2026
Title in English:
PYRROLOBENZODIAZEPINE CONJUGATESLanguage of the patent:
English
Timeline
Today
18.4.2018EP application
13.7.2022EP Publication
22.8.2022Translation submitted
15.9.2022Registration published
17.4.2026Expires
Owner
Name:
Medimmune LimitedAddress:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB
Inventor
Name:
HOWARD, Philip WilsonAddress:
Cambridge Cambridgeshire CB21 6GH, GB
Name:
GREGSON, Stephen JohnAddress:
Cambridge Cambridgeshire CB21 6GH, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201706133Date:
18.4.2017Country:
GB
Number:
201721337Date:
19.12.2017Country:
GB
Classification
Categories:
C07D 519/00, A61P 35/00, A61K 47/68, C07K 5/062
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 11.4.2023
Expires: 17.4.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 20.3.2024
Expires: 17.4.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.4.2025
Expires: 17.4.2026
Payer: Árnason Faktor ehf.